On February 25, 2016, Ernest Mario, Ph.D., advised Kindred Biosciences, Inc. of his intention to retire as a director of the company on the date of the company's 2016 Annual Stockholders' Meeting, which is scheduled to occur on May 23, 2016. Dr. Mario has served as a member of the company's Board of Directors since February 15, 2013 and currently serves as the Chairman of the company's Audit Committee and as a member of its Compensation Committee and Nominating and Corporate Governance Committee. Dr. Mario has provided distinguished service to the company, and his decision to retire as a director is not the result of any disagreement with other Board members or with the company's management.
Kindred Biosciences, Inc.
Equities
KIN
US4945771099
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+18.72% | 13TCr | |
+14.19% | 11TCr | |
-4.93% | 2.46TCr | |
+3.23% | 2.28TCr | |
-10.44% | 1.82TCr | |
-41.74% | 1.65TCr | |
-13.31% | 1.65TCr | |
+2.44% | 1.34TCr | |
+27.89% | 1.11TCr |